Exacerbation of COVID-19 mortality by the fragmented United States healthcare system: A retrospective observational study
- PMID: 35582265
- PMCID: PMC9098098
- DOI: 10.1016/j.lana.2022.100264
Exacerbation of COVID-19 mortality by the fragmented United States healthcare system: A retrospective observational study
Abstract
Background: Before widespread vaccination, the United States was disproportionately affected by COVID-19 with a mortality rate several times that of other affluent societies. Comparing regions with different rates of health insurance, we assess how much of this excess mortality may be due to the relatively large population without health insurance.
Methods: We use daily surveillance data from the US Centers for Disease Control and Prevention (CDC) stratified by region, age group, gender, and race in regression analysis of daily COVID-19 cases, hospitalization, and mortality. COVID-19 data have been matched with structural characteristics of the region including average proportion with health insurance. As checks, we have estimated regressions for different time periods, different groups of states, and by comparing adjacent counties between states with and without Medicaid expansion.
Findings: Groups with lower health insurance coverage had significantly higher mortality as well as greater case counts and hospitalization. Early in the pandemic, they were also less likely to be tested for COVID-19. Applying our regression estimates, we estimate that had there been full health insurance coverage of the population, there would have been 60,000 fewer deaths, 26% of the total death toll in the period of this analysis.
Interpretation: Our study demonstrates that a significant share of COVID-19 mortality in the United States, and much of the excess mortality in the United States compared with other countries, is due to our reliance on a system of market-driven healthcare. Providing universal insurance coverage should be part of our campaign to reduce COVID-19 mortality. It also suggests that these concerns should not be restricted to COVID-19 but apply across all diseases, contributing to many unnecessary deaths in the United States each year even apart from the COVID-19 pandemic.
© 2022 The Authors.
Conflict of interest statement
None.
Figures
References
-
- Lopez G. How the US's Covid-19 death toll compares to that of other wealthy countries. 2021; published online Jan 11.https://www.vox.com/future-perfect/2021/1/11/22220827/covid-19-pandemic-.... Accessed 4 March 2022.
-
- How do healthcare prices and use in the U.S. compare to other countries? Peterson-KFF health system tracker. 2018; published online May 8. https://www.healthsystemtracker.org/chart-collection/how-do-healthcare-p.... Accessed 4 March 2022.
-
- How does U.S. life expectancy compare to other countries? Peterson-KFF health system tracker. 2021; published online Sept 28.https://www.healthsystemtracker.org/chart-collection/u-s-life-expectancy.... Accessed 4 March 2022.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
